United Therapeutics buy Wells Fargo & Company
Start price
08.12.23
/
50%
€224.60
Target price
08.12.24
€287.40
Performance (%)
13.13%
Price
04.06.24
€251.10
Summary
This prediction is currently active. The prediction currently has a performance of 13.13%. This prediction currently runs until 08.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
United Therapeutics | 1.332% | 1.332% |
iShares Core DAX® | -1.042% | 2.220% |
iShares Nasdaq 100 | -1.361% | 3.207% |
iShares Nikkei 225® | -0.044% | -1.680% |
iShares S&P 500 | -0.480% | 2.165% |
Comments by Wells_Fargo___Compan for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $309.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€220.00
07.03.24
07.03.24
€298.84
07.03.25
07.03.25
14.14%
04.06.24
04.06.24